Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

Status quo is news if it affects the shareholders

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36568
(Total Views: 437)
Posted On: 02/15/2022 10:43:23 AM
Posted By: hylander
Re: FanMail #34960
Status quo is news if it affects the shareholders and impacts them in a negative way, all the while it is found out that a CEO is still having no problems talking on other social media platforms concerning viruses, vaccines and their companies, yet does not mention the companies he is CEO over. That is continuous news because investors are aware of it and it is impacting them and out of all of it, people have questions as to why, but no answers from anyone, especially Generex / NuGenerex.

There is a level of frustration on this board and basically across anywhere that Generex is being traded or has been and shareholders has bought shares at higher prices only to see the PPS drop to .06, For months everyone has clamored for news, seeing a status quo is not acceptable for anyone as seen by people throwing their hands up and simply selling and taking big losses because they are tired of this whole mess.

Who is responsible? No one knows. Everyone speculates, but because we see the status quo, people seem to just accept it. Let's email Todd and hear the same thing he gave a year or two years ago. Oh look, another Board member left. However no one is saying anything on why, what is going on, who did what, where are the deals, nothing. Where are all the old timers who have great relationships with Joe? Joe doesn't seem to mind running his mouth off to people, so what happened or is happening?

The status quo needs to be explained once and for all for a company that has all of this science, all of these products, all of these billion and million dollar deals. Anything less is totally unacceptably to every shareholder.


(1)
(0)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us